All lobbying filings

STANTON PARK GROUP

Lobbying for MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act
HR 2484
Seniors’ Access to Critical Medications Act of 2025

Lobbying activity 2

Medicare/Medicaid

Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act.

Health Issues

H.R.2484, Seniors Access to Critical Medications Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.